Top

News & Events

Client News

Client News Our News Insights Features

20 December 2018
Immatics: Nature publication reports first-in-human trial for a personalized cancer immunotherapy

17 December 2018
HOOKIPA Doses First Patient in a Phase 2 Clinical Trial of Prophylactic Vaccine Candidate HB-101 against Cytomegalovirus

17 December 2018
Imugene Meets Endpoints in Phase 1b Gastric Cancer Immuno-oncology Trial

17 December 2018
Forbion Portfolio Company Staten Biotechnology Enters into a Collaboration with Novo Nordisk to Develop Novel Treatment for Dyslipidaemia

13 December 2018
Uncertainty for pharma and biotech in 2019 as sector stumbles at the end of 2018

10 December 2018
Interim Durability Analysis of PTX-200 in Breast Cancer Responders Demonstrates No Disease Progression

06 December 2018
Valneva and HOOKIPA Sign a Collaboration and Manufacturing Agreement

06 December 2018
SpeeDx Receives CE-IVD Mark for ResistancePlus® GC

06 December 2018
Confo Therapeutics Appoints Frank Landolt as its Chief Counsel Legal & Intellectual Property

03 December 2018
MISSION THERAPEUTICS: Dr Nick Edmunds Appointed to VP, Head of DUB Discovery

29 November 2018
Feedback plc - Final Results for year ended 31 May 2018: Invoiced sales up 51% following significant contract, investment and restructuring

29 November 2018
Forbion Appoints Dr. Carlo Incerti as Operating Partner

28 November 2018
HOOKIPA and DarwinHealth Enter into a Research Collaboration and License Agreement to Discover and Prioritize Novel Immunogenic, Tumor-Specific Cryptic Antigens

27 November 2018
UCL Spin-out Engitix Closes £5m Financing to Progress Liver Disease and Pancreatic Cancer Drug Discovery Platform and Pipeline

26 November 2018
Immune Regulation announces positive results from Phase 1 clinical trial of PIN201104

22 November 2018
Peptinnovate announces change of name to Immune Regulation, strengthening of the Board and successful fundraise

20 November 2018
SkinBioTherapeutics plc: Commencement of final phase of human studies

19 November 2018
Forbion Leads €40m Series B Financing in Inflazome to Develop NLRP3 Inflammasome Inhibitors to Clinical Proof-of-Concept

19 November 2018
Restoring sight: Clinical progress towards Australia’s bionic eye

15 November 2018
Board Appointment

15 November 2018
Mission Therapeutics and AbbVie sign DUBs Collaboration in Alzheimer’s and Parkinson’s Disease

14 November 2018
HOOKIPA Appoints Julie O’Neill as a Non-Executive Director

12 November 2018
National Care Group completes acquisition of Face 2 Face in Gloucester

12 November 2018
AMAL Therapeutics finalises €29 million (CHF 33.2 million) Series B round

12 November 2018
Icosabutate latest data shows direct and potent anti-fibrotic effect in both differentiated rodent NASH models and human stellate cells

07 November 2018
SkinBiotix® technology generates positive data in first two elements of its human study

05 November 2018
Xellia Pharmaceuticals Announces the Launch of First US Market Product Vancomycin Hydrochloride for Injection, USP

05 November 2018
Next decade set to herald industry confidence in microbiome-based therapies, says new report

05 November 2018
Crescendo Biologics announces early licensing by Takeda of first oncology-targeted Humabody®

02 November 2018
Microbiotica Wins Life Sciences Company of the Year at Cambridge Independent Awards

02 November 2018
DNAe: Breakthrough in Rapid Diagnostic for Antimicrobial Resistance

02 November 2018
National Care Group expands into Devon with first acquisition - Atlantic Support (Devon) Ltd

02 November 2018
Dr. Axel Mescheder Appointed CEO of Cristal Therapeutics as Focus Intensifies on Proprietary Oncology Nanomedicine Pipeline

02 November 2018
Forbion Leads €17m Series C Financing of OMEICOS Therapeutics

01 November 2018
F-star to Disclose Targets and Preclinical Data on New Agonist Bispecific Antibody Programmes

30 October 2018
BioScience Managers appoints Dr. Kate Rowley as UK-based Investment Director

30 October 2018
Microbiotica Participates in Microbiome Panel Discussion at this year’s Bio-Europe®

29 October 2018
EBD Packs Partnering Power into its partneringONE® Platform in Preparation for BIO-Europe® 2018

26 October 2018
Recce Meets Antibiotic Leaders to Explore Commercial and Clinical Opportunities

25 October 2018
SkinBioTherapeutics - Full Year Results

25 October 2018
Feedback plc - Proposed placing and subscription to raise £1.375 million

25 October 2018
Cristal Therapeutics Initiates Phase 2 Clinical Trial of Innovative CriPec® Nanomedicine Drug Candidate in Ovarian Cancer

24 October 2018
Microbiotica Attracts Equity Investment from Seventure’s Health for Life Capital™ Fund

24 October 2018
Emergex Demonstrates Excellent Safety Profile for Gold Nanoparticle Used in its Vaccine Platform

23 October 2018
Epilepsy Society, UCL and Congenica Join Forces in Genomic Study to Identify Causes of Unexpected Deaths in Epilepsy

22 October 2018
Feedback expands its European customer base with new orders for TexRAD® from prestigious European university hospitals

22 October 2018
Polyganics Initiates First-in-Human Trial of LIQOSEAL®, its Innovative Approach for Dural Closure

18 October 2018
Crescendo Biologics Appoints SVP CMC, Dr Richard Williams, and New CDMO Partner, as It Advances Towards the Clinic

18 October 2018
AELIX Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement to Evaluate a Therapeutic Vaccine and TLR7 Agonist Regimen for HIV Cure

17 October 2018
Congenica earns major role in supporting world’s first routine national genomic medicine service

16 October 2018
DNAe Wins OBN Award for Best Diagnostic Medtech Company

15 October 2018
F-star Appoints Dr Eliot Forster as Chief Executive Officer

15 October 2018
National Care Group grows presence in County Durham with acquisition of Abbeyvale Care Centre

11 October 2018
Consort Medical plc: Doubts Over Data Security Denting Smart Inhaler Potential?

10 October 2018
Forbion Co-leads $54m Series A Financing in newly formed Gotham Therapeutics

09 October 2018
New PBS-Only Antibodies Enable More Flexible Research

09 October 2018
National Care Group completes acquisition of Cleveland House

08 October 2018
Aglaris Appoints New CEO to Drive Commercialisation of Ground-breaking Cell-based Therapy Manufacturing System

08 October 2018
European Society for Medical Oncology President joins Imugene Scientific Advisory Board

04 October 2018
BioForward - The 'Roadmap for Growth' Life Sciences Event

04 October 2018
European Facility Updates from Consort Medical

03 October 2018
Feedback plc trading update – commercial progress and US market strategy

03 October 2018
Leading Pharma Executive Kate Hilyard Joins Healx to Drive the Integration of AI with Drug Discovery for Rare Diseases

01 October 2018
Forbion Closes Oversubscribed Fourth Life Sciences VC Fund at EUR 360 million

27 September 2018
DNAe Wins Inaugural 2018 Medtech Insight Top Innovator Award

25 September 2018
Evaluate Ltd: Worldwide medtech sales forecast to reach $595 billion by 2024, with a CAGR of 5.6%, anchored by familiar players

20 September 2018
Cell Medica: First neuroblastoma patient successfully dosed with innovative CAR therapy utilizing natural killer T cells (CAR-NKT)

20 September 2018
Emergex Enters into MoU with Brazil’s Fiocruz to Develop Novel Vaccines Against Viral Diseases

19 September 2018
Abzena announces a research and licence agreement with Tmunity Therapeutics

19 September 2018
SkinBioTherapeutics plc: Human study commenced

18 September 2018
Xellia Pharmaceuticals Opens North American Commercial Office in Chicago Ahead of Launching Value-Added Anti-Infective Injectable Drug Products

17 September 2018
Congenica Announces Market Access Partnership with Digital China Health to Enable Genomic Medicine in the Chinese market

11 September 2018
Imugene Completes Phase 1b Cancer Vaccine Trial Recruitment

11 September 2018
Crescendo Biologics Strengthens its Management with the Appointment of Dr Pavel Pisa as Chief Medical Officer

10 September 2018
F-star Appoints Nessan Bermingham as Chairman of its Board of Directors

10 September 2018
TexRAD® ordered by Samsung Medical Centre in South Korea

10 September 2018
Biopharma Company Arecor raises £6m for revolutionary diabetes treatments

10 September 2018
Polyganics Strengthens Global Distribution Network with Appointment of Synovis MCA as US-wide Distributor of NEUROCAP®

06 September 2018
LEUKOCARE and Xellia Pharmaceuticals partner to discover innovative formulations for the development of value-added anti-infective therapies

05 September 2018
Seventure Partners Life Sciences Corporate Update

04 September 2018
Mission Therapeutics Strengthens Clinical Development Team with Appointment of Dr Judit Molnar as Senior Director, Translational Medicine

03 September 2018
SkinBiotix® technology successful in stability testing

28 August 2018
Congenica Appoints Wendy Britten as Chief Financial Officer

20 August 2018
Small drug developers continue to hold all the cards, while young device makers suffer from a shrinking pool of buyers

16 August 2018
Immatics Initiates Second Phase I Clinical Trial of its Unique ACTengine®Platform in Patients with Advanced Solid Cancers

16 August 2018
SkinBioTherapeutics plc Business update

15 August 2018
DNAe Chosen as Best Diagnostic Medtech Company Finalist in the 2018 OBN Awards

15 August 2018
Feedback plc: First GE Healthcare order for TexRAD® medical imaging software

15 August 2018
Crescendo Biologics Reaches Technical Milestone for a Second Target in Strategic Collaboration with Takeda

08 August 2018
DNAe Named as Top Innovator Finalist in the Inaugural 2018 Medtech Insight Awards

08 August 2018
Release of first GMP drug substance for an ABZENA Inside product manufactured by Abzena

01 August 2018
Cell Medica Appoints New CEO to Drive CAR and TCR Clinical Development and Commercialisation

31 July 2018
Key Australian Patent for Recce’s Broad-Spectrum Antibiotics

31 July 2018
MerLion Regains North American Rights to XTORO™ FDA-Approved Antibiotic for Treatment of Ear Infections

31 July 2018
Abzena signs protein engineering agreement with NYU Langone Health

26 July 2018
Healx Raises $10m as Investors Back AI to Find Rare Disease Treatments Faster

26 July 2018
Forbion Portfolio Company Replimune Successfully Completes IPO on NASDAQ

25 July 2018
Mobile Responsive Technology Powers Biotech-Pharma Business Growth through an Enhanced partneringONE® Conference Software Experience

25 July 2018
Clinigen acquires global rights to Imukin® from Horizon Pharma

24 July 2018
F-star Announces the Achievement of a Clinical Milestone in its Immuno-Oncology Collaboration with Merck

18 July 2018
SkinBioTherapeutics receives provisional ethics approval for human study

17 July 2018
Clinigen acquires global rights to Proleukin® outside the United States

17 July 2018
Update on Progress of Broad Spectrum Antibiotic RECCE®327 Towards Clinical Trials

17 July 2018
Clinigen Year end trading update

12 July 2018
Immatics Enters into a Strategic Partnership with Genmab to Develop Next Generation Bispecific Cancer Immunotherapies

11 July 2018
Forbion exceeds target with EUR 270 million first close of its fourth life sciences VC fund

02 July 2018
Abzena and Telix sign strategic manufacturing and bioconjugation agreement

02 July 2018
Crescendo Biologics Appoints Clinical Development Expert, Dr Igor Matushansky, as Non-Executive Director

02 July 2018
Abcam Merck Collaboration Produces New PD-L1 Antibody for Immuno-Oncology Research

26 June 2018
Reapplix: Positive outcome data of large Randomized Controlled Trial presented at American Diabetes Association Scientific Sessions and Business Update

19 June 2018
Neural Analytics, Inc. Receives CE Mark for its Robotic Ultrasound System

18 June 2018
National Care Group marks major expansion in the West Midlands with acquisition of Shelton Care

18 June 2018
Microbiotica Collaborates with University of Adelaide to Develop a Novel Microbial Therapy for Ulcerative Colitis

18 June 2018
Crescendo Biologics Appoints Eva-Lotta Allan as Non-Executive Director

14 June 2018
Clinigen signs exclusive supply & distribution agreement with Lukare for Elliotts B® Solution

14 June 2018
Dirk Kersten joins Forbion as General Partner

13 June 2018
Cell Medica Appoints Julia P. Gregory as Non-Executive Director and Audit Chair

13 June 2018
Xellia Pharmaceuticals Appoints Matthew Anderson as Chief Financial Officer

06 June 2018
Worldwide Prescription Drug Sales Accelerate to $1.2 Trillion by 2024, as Unmet Need Drives Annual Compound Growth to Over 6%

06 June 2018
Microbiotica Enters into Microbiome Collaboration with Genentech

05 June 2018
Hookipa and Gilead Enter into a Collaboration and License Agreement to Develop Immunotherapies Against HIV and Hepatitis B

05 June 2018
Recce Pharmaceuticals: Update on meeting with US FDA

04 June 2018
Future Oncology publishes dexrazoxane article supporting EC removal of restrictions for use in children and adolescents

04 June 2018
Full year results: a year of transition - revenue growth driven by investment programme

31 May 2018
Clinigen and Bristol-Myers Squibb sign extended partnership agreement in South Africa

31 May 2018
F-star Announces Early Exercise by Denali Therapeutics of its Option to Acquire F-star Gamma

30 May 2018
Zai Lab and Crescendo Biologics Enter Exclusive Worldwide License Agreement for Innovative Protein Therapeutics for Inflammatory Indications

29 May 2018
Worldwide Orphan Drug Sales are Forecast to Grow at a CAGR of 11.3% from 2018 to 2024, Double the Rate Forecast for the Non-Orphan Drug Market

29 May 2018
SkinBioTherapeutics to fulfil industrial partner role in skin health research grant awarded to the University of Manchester

24 May 2018
Clinigen signs agreement with Nordic Pharma for aprotinin

24 May 2018
Emergex Files a Patent in the USA for its novel Pandemic Flu Vaccine

24 May 2018
Agendia and Angsana to Provide Breast Cancer Risk-of-Recurrence Testing with MammaPrint® and BluePrint® to Patients in Southeast Asia

22 May 2018
Microbiotica to Present at Top Microbiome Conferences

22 May 2018
Clinigen and Mitsubishi Tanabe initiate European Managed Access Program for edaravone to treat ALS

21 May 2018
F-star Announces First Patient Dosed in Phase I Clinical Trial of FS118, a First-in-class Immuno-oncology Bispecific Antibody

16 May 2018
Seventure Partners Life Sciences Corporate Update January - April 2018

15 May 2018
New Insights into Hookipa’s TheraT® Replicating Viral Vector Platform published in Immunity

15 May 2018
Agendia’s MammaPrint® and BluePrint® Breast Cancer Tests Selected by Unicancer for French Patients

14 May 2018
Immatics Appoints Stephen Eck as Chief Medical Officer US

14 May 2018
Acousia Therapeutics Announces €10 Million Series B Financing to Advance its Hearing Loss Portfolio

14 May 2018
Emergex Awarded Innovate UK Grant to Progress its Universal and Pandemic Flu Vaccine

09 May 2018
Astex’s Harren Jhoti made Fellow of the Royal Society

01 May 2018
SkinBioTherapeutics finalises plans for human study of cosmetic application and progresses manufacturing scale-up

30 April 2018
Crescendo Biologics Ltd. Raises $70 Million (€57 Million) in Series B Financing

27 April 2018
Belgian Microbiome Spin-off A-Mansia Announces €13m First Close of Series A Financing

24 April 2018
Rapid Detection of Pathogen and Antibiotic Resistance with DNAe’s LiDia® Bloodstream Infection (BSI) Technology

24 April 2018
Recce Pharmaceuticals: Pharmaceutical Expert Joins Board of Directors

24 April 2018
BioScience Managers: Downing FOUR VCT invests £1.14 million in ADC Biotechnology Ltd

23 April 2018
Additional AU$861,590 R&D Tax Incentive Rebate for RECCE® 327 Antibiotic

23 April 2018
Xellia Pharmaceuticals Appoints Craig Boyd as President, Xellia US as it Expands its Commercial Organization in Preparation for the Launch of its Value-Added Anti-Infective Drug Products

17 April 2018
SkinBioTherapeutics’ technology, SkinBiotix®, shows positive results in cream formulation

16 April 2018
Crescendo Biologics Reaches First Major Milestone in Strategic Collaboration with Takeda

13 April 2018
DNAe to Present New Data and Preview its Blood-to-Result Test for Bloodstream Infection at ECCMID 2018

12 April 2018
PTX-200 Phase 1b Breast Cancer Trial Results Prescient’s Most Significant Clinical Milestone to Date

12 April 2018
Forbion participates in £29M Series B Financing of Enterprise Therapeutics to Advance its Ion Channel Modulators for the treatment of Cystic-fibrosis, COPD and severe asthma

12 April 2018
MerLion Pharmaceuticals: Positive Phase II Data of Finafloxacin Antibiotic Published in Three Papers in Antimicrobial Agents and Chemotherapy

12 April 2018
NorthSea Therapeutics: Potential of icosabutate as a novel approach to the treatment of NASH highlighted in late-breaker at The International Liver CongressTM 2018

09 April 2018
F-star to Present New Preclinical Data on FS118, a First-in-Class Immuno-Oncology Bispecific Antibody, at the AACR 2018 Annual Meeting

03 April 2018
SkinBioTherapeutics signs Material Transfer Agreement with global consumer goods company

29 March 2018
Sir David King Joins Emergex’s Board of Directors

28 March 2018
April Funding Update

28 March 2018
Emergex builds its Finance Team with Two New Recruits

27 March 2018
Hookipa Biotech to Present New Phase 1 Data for its Cytomegalovirus Vaccine, HB-101 at the World Vaccine Congress

27 March 2018
CMO Appointment and Clinical Trials Update

27 March 2018
e-therapeutics - Full Year Results

26 March 2018
Emergex Progresses its Synthetic Vaccine Development Pipeline

26 March 2018
Facility remodelling completed for Abzena’s new antibody-drug conjugate GMP manufacturing suite

21 March 2018
Xellia Pharmaceuticals Reports on Strong 2017 Financial Results and Advances in the Development of its Novel Premixed Vancomycin Ready-to-Use (RTU) Bag

21 March 2018
Agendia Announces CE Mark for NGS-Based MammaPrint® BluePrint® Kit Enhancing Access to Personalized Treatment for Breast Cancer Patients in Europe

21 March 2018
Crescendo Biologics Appoints Dani Bach as Non-Executive Director

20 March 2018
Adisseo and Seventure Partners Announce €24m First Close of AVF, a New Fund Dedicated to Innovative Animal Health and Nutrition

20 March 2018
OBN BioTuesday 2018

19 March 2018
Clinigen appointed by Jazz Pharmaceuticals to manage Managed Access Program for Vyxeos® (CPX-351) outside the United States

19 March 2018
Medicxi unveils ‘The Foundation Institute’

16 March 2018
Forbion’s Portfolio Company, Prexton Therapeutics Acquired by Lundbeck for up to EUR 905 million (USD 1.1 billion)

15 March 2018
Astex Continues to Deliver in Oncology as Erdafitinib, a Potential New Treatment for Metastatic Urothelial Cancer, Receives US FDA Breakthrough Therapy Designation

13 March 2018
Forbion leads $19 Million Series B Financing of Escalier Biosciences to Advance its Topical and Systemic RORγt Therapies for Psoriasis and other Autoimmune Diseases

13 March 2018
Abzena Strengthens Specialized Bioassay Offering Through Access Agreement with Major Cell Line Depository

08 March 2018
Meeting with US FDA on Phase I Clinical Trial for RECCE® 327 Antibiotic

08 March 2018
FDA Grants Breakthrough Device Designation to Polyganics’ Liver and Pancreas Sealant Patch

08 March 2018
Mission Therapeutics Appoints Dr Bobby Soni to its Board of Directors

06 March 2018
Clinigen strengthens senior management team in Clinical Trial Services and Commercial Medicines

01 March 2018
Mission Therapeutics Strengthens Senior Management Team with Appointment of Dr Paul Thompson, Vice President, Clinical Development

28 February 2018
Evaluate Ltd: Fast Pace of Drug and Device Approvals in 2017 Signals Wider Sector Health for Biopharma but Medtech Companies Struggle

28 February 2018
Congenica Achieves Global ISO 13485:2016 in vitro Diagnostic Device Quality Management Systems Certification

27 February 2018
Clinigen: Good H1 performance with adjusted EPS up 13%

21 February 2018
SkinBioTherapeutics plc: Half year results

21 February 2018
Dimerix Raises a Further AU $4.5m Through Oversubscribed Placement

20 February 2018
Clinigen and Santhera launch US Expanded Access Program with Idebenone for patients with Duchenne Muscular Dystrophy

16 February 2018
Kevin S. Boyle, Sr. Appointed CFO to Lead Cell Medica Financing for Innovative CAR and TCR Cell Therapies

15 February 2018
Data Submission & Further Communication Request with US FDA

12 February 2018
Auspherix Awarded Innovate UK Grant to Test its Organogold Antibiotics to Treat Life-threatening Respiratory Infections

12 February 2018
Congenica and SFI Research Centre FutureNeuro Unite to Deliver More Accurate Diagnoses for Genetic Epilepsy

09 February 2018
Biotech and Money Reports 20% of investors shift focus to life science investment opportunities outside of the UK due to Brexit

07 February 2018
New CatchPoint® SimpleStep® ELISA Fluorescent 90-Minute Assay

06 February 2018
Hookipa Biotech to Attend the LEERINK Partners 7th Annual Global Healthcare Conference

06 February 2018
Introducing FirePlex®-HT High-Throughput Multiplex Immunoassays – Delivering More Data from Precious Samples

05 February 2018
Abcam and Molecular Devices Announce Strategic Collaboration

01 February 2018
Congenica Signs Strategic Digital Health Contracts During Official UK-China Trade Mission

29 January 2018
Dimerix Limited Quarterly Review - Q2 FY2018

26 January 2018
Harren Jhoti Receives Lifetime Achievement Award from the UK BioIndustry Association

25 January 2018
Synthon’s [vic-]trastuzumab duocarmazine (SYD985) granted FDA Fast Track designation for pre-treated HER2-positive metastatic breast cancer

25 January 2018
Congenica Appoints New CEO to Drive Global Expansion of Clinical Genomics Business

23 January 2018
Atomo Diagnostics and Access Bio partner to expand access to best-in-class HIV rapid testing in global markets

22 January 2018
Seventure Joins $35m Series B Round in Digital Nutrition Platform Zipongo

22 January 2018
Abcam Signs Exclusive License Agreement with Roche

19 January 2018
Biotech and Money presents Biotech and Money/Medtech and Money World Congress on 5-6 February 2018

17 January 2018
FuturaGene’s Exclusive License For RNAi Technology In Eucalyptus Enhanced By Grant Of Patent In Brazil

17 January 2018
Immatics Appoints Thomas Ulmer as Chief Financial Officer

17 January 2018
Clinigen Group plc: HY trading update: good H1 performance with profits up over 10%

15 January 2018
e-Therapeutics to collaborate with Intellegens and Biorelate to enhance and extend its AI technology capabilities

15 January 2018
AusIndustry Awards Recce Support for AU$5.6m of Technically Advanced Overseas Drug Development

11 January 2018
Seventure Partners Life Sciences Investing Update - H2 2017

05 January 2018
Abzena takes on new facilities in Cambridge, UK and San Diego

03 January 2018
Clinigen extends agreement with Eisai to supply Halaven®, Fycompa® and Lenvima® into 10 African countries